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Association between quality of life and
various aspects of intradialytic hypotension
including patient-reported intradialytic
symptom score
Johanna Kuipers1* , Jurjen K. Oosterhuis2, Wolter Paans3, Wim P. Krijnen3, Carlo A. J. M. Gaillard2,4,
Ralf Westerhuis1 and Casper F. M. Franssen2
Abstract
Background: There is increasing awareness that, besides patient survival, Quality of Life (QOL) is a relevant outcome
factor for patients who have a chronic disease. In haemodialysis (HD) patients, intradialytic hypotension (IDH) is
considered one of the most frequent complications, and this is often accompanied by symptoms. Several studies have
investigated QOL in dialysis patients, however, research on the association between intradialytic symptoms and QOL is
minimal. The goal of this study was to determine whether the occurrence of IDH has an influence on the perception
of QOL.
Methods: During 3 months, haemodynamic data, clinical events, and interventions of 2623 HD-sessions from
82 patients were prospectively collected. The patients filled out a patient-reported intradialytic symptom score
(PRISS) after each HD session. IDH was defined according to the EBPG as a decrease in SBP ≥20 mmHg or in
MAP ≥10 mmHg associated with a clinical event and need for nursing interventions. Patient’s self-assessment
of QOL was evaluated by the 36-Item Short-Form Health Survey.
Results: There were no significant associations between the mental summary score or the physical summary
score and the proportion of dialysis sessions that fulfilled the full EBPG definition. A lower PRISS was significantly
associated with the proportion of dialysis sessions that fulfilled the full EBPG definition (R = − 0.35, P = 0.0011), the
proportion of dialysis sessions with a clinical event (R = − 0.64, P = 0.001), and the proportion of dialysis sessions with
nursing interventions (R = − 0.41, P = 0.0001). The physical component summary and mental component summary
were significantly negatively associated with the variable diabetes and positively with PRISS (P = 0.003 and P = 0.005,
respectively). UF volume was significantly negatively associated with mental health (P = 0.02) and general health
(P = 0.01).
Conclusions: Our findings suggest that the EBPG definition of IDH does not capture aspects of intradialytic
symptomatology that are relevant for the patient’s QOL. In contrast, we found a significant association between
QOL and a simple patient-reported intra-dialytic symptom score, implying that how patients experience HD
treatment influences their QOL.
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Background
In the past 10 to 15 years, there has been an increasing
awareness that patient survival is not necessarily the
main relevant outcome factor for patients with a chronic
disease. Patient reported outcomes and Quality of Life
(QOL) receive, with good reason, increasing attention in
research regarding patients with chronic diseases, such
as patients with end stage renal disease who depend on
dialysis [1, 2]. To assess QOL, the RAND SF-36 (SF-36)
has been proven to be beneficial for comparing general
and specific populations, estimating the relative burden
of different diseases, assessing the health benefits pro-
duced by a wide range of different treatments, and
screening individual patients [3].
Intradialytic hypotension (IDH) is a serious and
frequent complication of haemodialysis (HD) treat-
ment [4, 5] It is often accompanied by symptoms
such as nausea, dizziness, light-headedness, fatigue,
and muscle cramps which affect the daily lives of HD
patients [6] and, consequently, likely influence QOL.
Pathophysiology of intradialytic hypotension and the
methods to avoid this complication have been ex-
tensively investigated [7, 8]. Also, the association
between IDH and mortality has been studied by
several groups [7, 8], Flythe et.al. showed that an
absolute nadir systolic blood pressure (SBP) < 90mmHg
was most potently associated with mortality [8]. In con-
trast, research on the association between intradialytic
symptoms and QOL is minimal. Caplin et.al. studied the
burden and duration of HD-associated symptoms with
a survey but did not study the association between
symptoms and QOL [6].
To support patients in effectively improving QOL,
more knowledge is needed on the association between
QOL and HD treatment-related factors like IDH.
Furthermore, there is a need to identify aspects of
IDH that have a (strong) effect on QOL. The goal of
this study, therefore, was to determine whether the
occurrence of IDH has an influence on the perception
of QOL in HD patients. We studied this in a
well-characterized patient group of 82 patients on
maintenance HD over a period of 3 months compris-
ing a total of 2623 HD-sessions. The focus of the
study was on the association of QOL with the full
definition of IDH according to the European Best
Practice Guideline (EBPG) on haemodynamic instabil-
ity as well as with its three components, i.e., a de-
crease in SBP of > 20 mmHg, the occurrence of
clinical events, and nursing interventions [9]. To gain
better insight into how the patients experienced the
overall HD treatment, we additionally employed a
simple patient-reported intradialytic symptom score




This is a post-hoc analysis of a previous study on the
prevalence of dialysis hypotension [10].
This multicenter prospective observational study
included adult (≥18 years) patients from the Dialysis
Center Groningen and the dialysis unit of the University
Medical Center Groningen. Patients were eligible for the
study when they satisfied the following criteria: mainten-
ance bicarbonate HD for more than 3 months, three
times per week, 3 ½ -4 ½ hours HD schedule. This study
was approved by the Medical Ethical Committee of the
University Medical Center Groningen. The Committee
concluded that the Medical Research Involving Human
Subjects Act (in Dutch: Wet Medisch-wetenschappelijk
Onderzoek met mensen) was not applicable to this
study (MEtc number: 2016/141). Obtaining oral
informed consent was judged appropriate for this
observational study that was conducted without inter-
vention and without obtaining any patient material.
All personal information was de-identified and ana-
lyzed anonymously. The study was performed in
accordance with the principles of the Declaration of
Helsinki.
Study protocol
The design an methods of this study haven been pre-
viously reported [10]. In brief we prospectively col-
lected the haemodynamic data, symptoms and nursing
interventions of all of the HD sessions from partici-
pating patients during the 3 months of February,
March, and April. All data were registered on a run
sheet and stored electronically. The patients were
asked to fill out a simple questionnaire after each HD
session, i.e., a patient-reported intradialytic symptom
score (PRISS). Patients scored how they had experi-
enced the HD session on a 5 point Likert scale ran-
ging from 0 (‘bad HD session’) to 5 (‘very good HD
session’) [11]. Patient’s self-assessment of QOL was
evaluated in the third month of the study by the
36-Item Short Form Health Survey (RAND SF-36)
scoring system in the Dutch version [12]. The SF-36
consists of 36 questions in eight categories: physical
functioning, physical role functioning, bodily pain,
general health perceptions, vitality, social role func-
tioning, emotional role functioning, and mental
health. Among the eight categories, the four physical
elements compose the physical component summary,
and the emotional, mental and social functioning
elements create the mental component summary.
Haemodialysis sessions during hospitalization were
excluded from the analysis. Ultrafiltration rate was
calculated by dividing ultrafiltration volume by dialy-
sis session length and postdialysis body weight.
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Cardiovascular history was defined as any history of
heart disease, stroke, or peripheral vascular disease. Re-
sidual diuresis was defined as ≥200 ml/24 h. Equilibrated
Kt/V was calculated from pre- and postdialysis plasma
urea concentration according to the second-generation
logarithmic Daugirdas equation [13].
Dialysis hypotension was defined according to the
EBPG definition [9]: a decrease in SBP ≥20 mmHg or
a decrease in MAP by ≥10 mmHg associated with a
clinical event and need for nursing interventions. In
additional analyses, we also used a decrease in SBP
≥30 and ≥ 40 mmHg as a designated limit. Patients
were marked to have frequent dialysis hypotension
when they fulfilled the EBPG definition of dialysis
hypotension in ≥10% of dialysis sessions. The cut-off
of 10% was arbitrarily chosen based on previous
studies in which the prevalence of IDH ranged from
5 to 50% depending on the definition that was used
[8, 10, 14–16]. Within this 5 to 50 range, we chose a
relatively low cut-off of 10% since we used a strict
definition of IDH.
Statistical analysis
Data are reported as mean(±SD) for continuous
variables with normal distributions, numbers (percent)
for categorical data and median (interquartile range)
for skewed data. The Shapiro Wilkinson test was used
to test normality. Comparisons between groups with a
normal distribution were made using a T-test, and for
groups with a skewed distribution using the Mann
Whitney U test. The Kruskal Wallis-test was used for
multiple groups.
For the analysis of pre-, intra- and postdialysis
haemodynamic parameters and PRISS, the data of all
available HD sessions were averaged per patient. For
the analysis of the components of QOL, a multi-
variate linear regression analysis with mixed effects
model was utilized to identify QOL factors associated
with IDH. This was followed by a model building
strategy based on the Akaike Information Criterion
(AIC model) [17–19]. Given the collection of possible
models for the data, minimum AIC best selected the
model by a maximum likelihood with a correction for
overfitting. The following parameters were included in
the model: age, gender, dialysis vintage, BMI, diabetic
status, comorbid heart conditions, predialysis SBP,
ultrafiltration volume, intradialytic clinical events,
nursing interventions, PRISS and, various, a decrease
in SBP of 20 mmHg, 30 mmHg, or 40 mmHg. Ana-
lyses were performed with SPSS version 20.0 (SPSS
inc., IBM company, USA), GraphPad Prism version
5.0 and statistical programming language R version
3.4.0 (R Core Team, 2017).
Results
Patients
Of the 124 patients that participated in the original
study, 82 patients filled out a QOL questionnaire.
Patients who did not do so were not familiar with the
Dutch language (n = 10), were mentally disabled (n = 4),
or could not fill out a questionnaire due to intercurrent
illness (n = 3). The reason for not filling out a question-
naire is unknown for 25 patients. There were no sig-
nificant differences in characteristics between the
patients who filled out the QOL questionnaire and those
who did not.
The characteristics of the 82 patients are shown in
Table 1. Mean (±SD) haemoglobin and albumin levels
were 7.0 ± 0.8 mmol/l and 39.6 ± 3.1 g/l, respectively.
eKt/V was 1.39 ± 0.26 per session. Haemodialysis access
was an arteriovenous fistula or polytetrafluoroethylene
(PTFE) graft in 82% of patients and a central venous
Table 1 Patient characteristics
Characteristic n = 82
Age, year 64.1 ± 15.6
Dialysis vintage, months 32.0 ± 28.9
Males 41 (50%)
Diabetes 18 (22%)
Body mass index (kg/m2) 25.7 ± 5.0
Residual renal function 23 (28%)
Cardiovascular history 36 (44%)
Acute myocardial infarction 5 (6.1%)
Congestive heart failure 4 (4.9%)
Peripheral vascular disease 17 (20.7%)





Obstructive uropathy 14 (17%)
ADPKD 7 (9%)
IgA nephropathy 4 (5%)
Alports’ disease 1 (1%)





ACE-I/ ARB 16 (20%)
Note: continuous variables are presented as mean ± standard deviation
Abbreviations: ADPKD autosomal dominant polycystic kidney disease, CCB
calcium channel blocker; ACE-I angiotensin converting enzyme inhibitor, ARB
angiotensin receptor blocker
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catheter in 18% of patients. Cardiovascular medication
was being used by 67% of the patients.
A total of 2623 HD sessions were analyzed with an
average number of dialysis sessions per patient of 33
(range 14–36).
Weight, ultrafiltration volume, blood pressure, and
heart rate
The mean blood pressure decreased, from 145 ± 26 /
72 ± 15 mmHg predialysis to 130 ± 25 / 67 ± 14 mmHg
at the end of the HD session. The mean MAP
decreased from 96 ± 16 mmHg predialysis to 88 ± 17
mmHg postdialysis. The mean heart rate rose, from
75 ± 11 mmHg predialysis to 76 ± 14 bpm at the end
of the HD sessions. The mean pre- and postdialysis
body weight was 75.8 ± 15.4 kg and 73.9 ± 15.4 kg,
respectively. The mean ultrafiltration volume and
ultrafiltration rate in all 2623 dialysis sessions was
2457 ± 828 ml and 8.3 ± 3.1 ml/kg/hour, respectively.
IDH according to the full EBPG definition occurred
in 6.7% of the HD sessions.
Association of patient characteristics and intradialytic
hypotension variables with QOL
For the QOL component physical functioning, younger
patients had a significantly higher score (P = 0.003), and
patients with a longer dialysis vintage had a considerably
lower score (P = 0.002) (Additional file 1). Patients with
diabetes scored notably higher on the QOL component
pain (P = 0.04) (Additional file 1).
There were no significant associations between the
mental summary score or the physical summary score
and the proportion of dialysis sessions that fulfilled the
full EBPG definition nor with the proportions of dialysis
sessions that fulfilled one of the components of the
EBPG definition (decrease in SBP of > 20mmHg, clinical
event, nursing interventions) (Fig. 1).
Intradialytic hypotension variables and PRISS
There was no significant association between the
PRISS and the proportion of dialysis sessions in
which a decrease in SBP of > 20 mmHg occurred. A
lower PRISS was significantly associated with the pro-
portion of dialysis sessions that fulfilled the full EBPG
definition (R = − 0.35, P = 0.0011), the proportion of
dialysis sessions with a clinical event (R = − 0.64, P = 0.001),
and the proportion of dialysis sessions with nursing
interventions (R = − 0.41, P = 0.0001) (Fig. 1).
A lower PRISS score was significantly associated with
a lower score for the QOL components general health
(P = 0.02), health change (P = 0.03), and the physical
summary score (P = 0.02).
Multivariable analyses
In the multivariate linear regression model with
optimizing AIC, the outcome variables of physical
component summary and mental component summary
were significantly negatively associated with the
variable diabetes and positively with PRISS (P = 0.003
and P = 0.005, respectively) (Table 2). The response
variable physical functioning was significantly nega-
tively associated with age (P = 0.00), dialysis vintage
(P = 0.04) and PRISS (P = 0.004), and also negatively
but not significantly with BMI (P = 0.10). BMI was
significantly negatively associated with the response
variable social functioning (P = 0.05). The response
variable emotional role functioning was negatively but
not significantly associated with nursing interventions
(P = 0.08) and total UF volume (P = 0.15) and
significantly positively associated with clinical events
(P = 0.005) and with PRISS (P = 0.01) (Additional file 2).
UF volume was also negatively but not significantly
associated with QOL components social functioning
(P = 0.16), physical role functioning (P = 0.14), and
emotional role functioning (P = 0.15) and significantly
negatively associated with mental health (P = 0.02) and
general health (P = 0.01). These analyses included a
decrease in SBP of ≥20 mmHg as a correcting ex-
planatory variable. Analyses with predialysis SBP, a
decrease in SBP of ≥30 mmHg and ≥ 40 mmHg showed
identical results.
Discussion
In this study we found that there is no association
between QOL and IDH as defined according to the
EBPG guideline. This is factual for the standard EBPG
definition as well as when a decrease in SBP of ≥30
or ≥ 40 mmHg is chosen as the blood pressure decline
component instead of a decrease in SBP ≥20 mmHg
or a decrease in MAP ≥10 mmHg. These findings
suggest that the EBPG definition of IDH does not capture
aspects of intradialytic symptomatology that are relevant
for QOL. In contrast, we found a significant association
between QOL and a simple patient-reported intradialytic
symptom score, i.e., the PRISS, indicating that the way
patients experience HD treatment indeed influences QOL.
The association between age and dialysis vintage with
the physical functioning component of the QOL was
expected and is explained by deteriorating physical func-
tion as patients become older and are on the HD treat-
ment for a longer period of time [10, 20]. BMI was
significantly negatively associated with social function-
ing. Although HD patients with a higher BMI have been
reported to have better survival, a higher BMI may be
associated with a lower QOL in this population [21].
The association between diabetes and the QOL com-
ponents, emotional functioning, and pain are also in
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accordance with previous studies and are explained by a
higher prevalence of cardiovascular complication and
diabetic complications such as neuropathy [22, 23].
Our analyses show the association between QOL and
UF-volume, clinical events, and nursing interventions
which are parameters that are directly or indirectly related
to fluid restriction. For some patients, this is very difficult
to maintain, and this may cause stress and anxiety.
The analysis of IDH is complicated by the wide
variation in definitions of dialysis hypotension that are
used in the literature [10]. Some definitions only use a
minimum decrease (e.g., ≥20 or ≥ 30 mmHg) in SBP
[24–26]. Other definitions require a combination of
symptoms and interventions with a fall in blood pressure
[9, 16, 27]. In this study, there was no association
encountered between a decrease in SBP of either ≥20,
Fig. 1 Scatterplots with correlations between the full EBPG definition (upper panel) and de EGBG components decrease in SBP≥ 20mmHg
(second panel), clinical events (third panel) and nursing interventions (lowest panel) and physical component score, mental component score
and PRISS
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≥30, or ≥ 40mmHg and QOL. This finding suggests that
a reduction in SBP does not have a major impact on
QOL in HD patients. In our previous article we
described that various factors may affect predialysis
blood pressure, the transportation to the dialysis unit
can be stressfull as well as puncturing the fistula. In this
regard the predialysis blood pressure may not be a valid
value as reference point, as the early intradialytic fall
in blood pressure may be explained by the relief of
stress/anxiety, and not by dialysis-specific haemo-
dynamic stress [10].
Presently, there is no general consensus regarding the
best evidence-based indicators of IDH. We agree with,
e.g., Assismon et al., that the lack of such indicators has
hindered the data synthesis and the development of evi-
dence-based guidelines for the prevention and treat-
ment of IDH as well as prevented an accurate
estimation of the population burden of IDH and
patient risk assessment [28].
An absolute nadir intradialytic BP of SPB < 90 mmHg
was previously found to be associated with an increased
mortality risk; however, intradialytic symptoms and
interventions were not associated with this risk [8]. An
important question is whether mortality can be lowered
by preventing a decrease in SBP to < 90mmHg. This
may depend on the type of preventive measures that are
taken. Increasing dry weight or preventive intradialytic
administration of saline carries the risk of chronic
overhydration which has a strong negative impact on
survival [29].
Further research is needed to understand the under-
lying mechanisms of the IDH related symptoms and to
provide the patient with the optimal dialysis treatment
[30, 31]. The finding that the way patients experience
HD treatment influences QOL may underscore the im-
pact of dialysis on their personal life, not only for the
patient but, most likely, also for their family members
[32]. This information can be used by medical and
nursing staff to provide a frame of reference to better
understand the consequences on the daily life of
patients. In addition to focusing on the medical con-
dition and the blood pressure course during the HD
treatment, more attention to the factors that influence
QOL seems beneficial for patients.
An important observation is that clinical symptoms
and nursing interventions are not hard endpoints and
subject to bias, with variation between patients in
reporting symptoms and the threshold to start an inter-
vention between healthcare professionals. This also
applies for how patients interpreted their QOL and
symptoms and rated the HD treatment in the PRISS.
The PRISS is a 5-point Likert scale measuring a positive
or negative response to a statement which was suitable
for the question of how they had experienced the HD
session. The validity of the Likert Scale attitude meas-
urement can be compromised due to social desirability.
The SF-36 does not include symptoms and problems
that are specific to a particular condition, but SF-36
scales correlate substantially with most of the omitted
general health concepts and with the frequency and
severity of many specific symptoms [33]. Relative to
other published measures, the mental health, role- emo-
tional, and social functioning scale and the mental com-
ponent summary have been shown to be the most valid
mental health measures in the method of known
groups-validity. The physical functioning, role- physical,
and bodily pain scales and the physical component
summary have shown to be the most valid physical
health measures [33]. Future studies should preferably
use the QDQOL, since this tool is supplemented with
multi-item scales targeted at particular concerns of
individuals with a kidney disease and on dialysis. The
Table 2 Multivariate linear regression analysis with model building strategy Akaike Information Criterion (AIC); factors associated







































SE 5.78 0.19 0.003 9.59
P 0.11 0.13 0.06 0.005a 0.10
Est Estimate, SE Standard Error, T T-value, P P-value, CI Confidence Interval, U Upper bound, L Lower bound, a significant, UF Ultrafiltration volume, CV
Cardiovascular, R the variance of the QOL variables explained by the explanatory variables (in %)
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number of patients in our study is relatively low.
However, the long study duration of 3 months as well as
the frequent measurement of blood pressure and the
post-dialytic recording of the PRISS (and active search
for patient complaints at each dialysis session) re-
duced the possibility of underestimation of dialysis
hypotension. Another limitation of our study is that
we did not take into account seasonal variations in
BP. Our study was performed in February through
April and, therefore we do not have information on
seasonal variations. We also acknowledge that the re-
sults in our Dutch cohort may not be representative
for other populations that have a higher incidence of
diabetes and overweight and higher ultrafiltration rates.
Conclusion
Our findings suggest that the EBPG definition of IDH
does not capture aspects of intradialytic symptomatology
that are relevant for the patient’s QOL. In contrast, we
found a significant association between QOL and a
simple patient-reported intra-dialytic symptom score,
i.e., the PRISS, indicating that how patients experience
HD treatment influences their QOL. Further research is
needed to confirm our findings and to refine the defi-
nition of IDH based on the purpose for which the defi-
nition is used. More attention to the impact of symptom
burden of HD treatment is helpful for improving the
QOL of HD patients.
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